Discover comprehensive details about Carbimazole, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Carbimazole (Anti -Thyrox) is a pro-drug, prescribed for hyperthyroidism. It reduces the amount of thyroid hormone. The information provided on this page is intended to serve as a comprehensive ...

Please provide your email address to receive an email when new articles are posted on . The treatment of hyperthyroidism during pregnancy with both methimazole ...

Two widely used medicines — doxycycline and carbimazole — will soon carry stronger safety warnings after a national review of adverse drug reaction reports. After analysing patient-level safety data, ...

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Let ...

Agranulocytosis is the most severe adverse effect of antithyroid drug therapy. The findings of a novel study from Japan suggest that this complication occurs more frequently if higher rather than ...

The Central Drugs Standard Control Organisation (CDSCO) has directed all state and Union Territory (UT) drug regulators to mandate manufacturers of antibiotic doxycycline formulations and anti-thyroid ...

India’s top drug regulator has ordered updated safety warnings for two commonly prescribed medicines — the antibiotic doxycycline and the anti-thyroid drug carbimazole — following fresh evidence on ...

My 11 year old was diagnosed with graves disease about 3 months ago. She was on very high dosis of Carbimazole (40mg p day) and is down to 5mg twice daily. Some of her symptoms have started again (not ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

NEW DELHI: Two medicines used widely - antibiotic doxycycline and thyroid drug carbimazole - will soon carry stronger safety warnings, following a national review of adverse drug reaction reports.